Literature DB >> 14634102

Control of NKT cell differentiation by tissue-specific microenvironments.

Yang Yang1, Aito Ueno, Min Bao, Zhongying Wang, Jin Seon Im, Steven Porcelli, Ji-Won Yoon.   

Abstract

CD1d-restricted Valpha14 NKT cells play an important role in both Th1- and Th2-type immune responses. To determine whether NKT cells develop two functionally distinct subsets that provoke different types of responses, we examined the phenotypes and cellular functions of NK1.1(+) and DX5(+) T cells. We found that both NK1.1(+) and DX5(+) T cells are CD1d-restricted Valpha14 T cells with identical Ag specificities, phenotypes, tissue locations, and functions. Similar to the NK1.1 marker, the DX5 marker (CD49b) is expressed on mature NKT cells in both NK1.1 allele-positive and allele-negative strains. However, when NK1.1(+) and DX5(+) NKT cells isolated from different tissues were compared, we found that thymic and splenic NKT cells differed not only in their cytokine profiles, but also in their phenotype and requirements for costimulatory signals. Thymic NKT cells displayed the phenotype of activated T cells and could be fully activated by TCR ligation. In contrast, splenic NKT cells displayed the phenotype of memory T cells and required a costimulatory signal for activation. Furthermore, the function and phenotype of thymic and splenic NKT cells were modulated by APCs from various tissues that expressed different levels of costimulatory molecules. Modulation of NKT cell function and differentiation may be mediated by synergic effects of costimulatory molecules on the surface of APCs. The results of the present study suggest that the costimulatory signals of tissue-specific APCs are key factors for NKT cell differentiation, and these signals cannot be replaced by anti-CD28 or anti-CD40 ligand Abs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14634102     DOI: 10.4049/jimmunol.171.11.5913

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

1.  NKT cell stimulation with glycolipid antigen in vivo: costimulation-dependent expansion, Bim-dependent contraction, and hyporesponsiveness to further antigenic challenge.

Authors:  Adam P Uldrich; Nadine Y Crowe; Konstantinos Kyparissoudis; Daniel G Pellicci; Yifan Zhan; Andrew M Lew; Philippe Bouillet; Andreas Strasser; Mark J Smyth; Dale I Godfrey
Journal:  J Immunol       Date:  2005-09-01       Impact factor: 5.422

2.  Both CD1d antigen presentation and interleukin-12 are required to activate natural killer T cells during Trypanosoma cruzi infection.

Authors:  Malcolm S Duthie; Maria Kahn; Maria White; Raj P Kapur; Stuart J Kahn
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

3.  Migration and chemokine receptor pattern of colitis-preventing DX5+NKT cells.

Authors:  Matthias Hornung; Jens M Werner; Stefan Farkas; Hans J Schlitt; Edward K Geissler
Journal:  Int J Colorectal Dis       Date:  2011-06-07       Impact factor: 2.571

4.  Runt-related transcription factor 3 is involved in the altered phenotype and function in ThPok-deficient invariant natural killer T cells.

Authors:  Xia Liu; Shengxia Yin; Wenqiang Cao; Wei Fan; Lei Yu; Li Yin; Lie Wang; Jianli Wang
Journal:  Cell Mol Immunol       Date:  2014-02-24       Impact factor: 11.530

Review 5.  iNKT cell autoreactivity: what is 'self' and how is it recognized?

Authors:  Laurent Gapin
Journal:  Nat Rev Immunol       Date:  2010-03-12       Impact factor: 53.106

6.  Regulation of natural killer T-cell development by deubiquitinase CYLD.

Authors:  Andrew J Lee; Xiaofei Zhou; Mikyoung Chang; John Hunzeker; Robert H Bonneau; Dapeng Zhou; Shao-Cong Sun
Journal:  EMBO J       Date:  2010-03-11       Impact factor: 11.598

7.  Type I interferon contributes to noncanonical inflammasome activation, mediates immunopathology, and impairs protective immunity during fatal infection with lipopolysaccharide-negative ehrlichiae.

Authors:  Qin Yang; Heather L Stevenson; Melanie J Scott; Nahed Ismail
Journal:  Am J Pathol       Date:  2014-12-04       Impact factor: 4.307

8.  Modulation of invariant natural killer T cell cytokine responses by indoleamine 2,3-dioxygenase.

Authors:  Alberto Molano; Petr A Illarionov; Gurdyal S Besra; Chaim Putterman; Steven A Porcelli
Journal:  Immunol Lett       Date:  2008-01-28       Impact factor: 3.685

9.  Murine CD8 lymphocyte expansion in vitro by artificial antigen-presenting cells expressing CD137L (4-1BBL) is superior to CD28, and CD137L expressed on neuroblastoma expands CD8 tumour-reactive effector cells in vivo.

Authors:  Xiaocai Yan; Bryon D Johnson; Rimas J Orentas
Journal:  Immunology       Date:  2004-05       Impact factor: 7.397

10.  Rapid and reliable generation of invariant natural killer T-cell lines in vitro.

Authors:  Asako Chiba; Nadia Cohen; Manfred Brigl; Patrick J Brennan; Gurdal S Besra; Michael B Brenner
Journal:  Immunology       Date:  2009-11       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.